Americord Announces Appointment of Andrew Horne

NEW YORK–(BUSINESS WIRE)–#Americord–Americord, the fastest growing cord blood bank in the country, and a
leader in the advancement of umbilical cord blood, cord tissue, and
placenta tissue banking has announced that Andrew Horne has joined the
company as in-house interim General Counsel.

Mr. Horne brings over 15 years of relevant experience to Americord,
having represented companies in an array of fields including technology,
pharmaceutical, biotech, insurance, telecommunications, defense and
entertainment. Prior to joining Americord, he was a litigation partner
at Kirkland & Ellis LLP and taught international private law and tort
law at the University of Strathclyde in Glasgow, Scotland.

“As Americord continues to grow in the evolving field of stem cell
science and cord blood banking, we are pleased to have Andrew on the
management team.” says Martin Smithmyer, CEO and founder. “His
experience in the biotech sphere will help us navigate the regulatory
environment both in terms of operations and patient advocacy. ”

Mr. Horne is a current member of the Americord Registry Advisory Board.
He holds degrees from Harvard Law School (LL.M.), Glasgow Graduate
School of Law (Dip. L.P.) and University of Strathclyde (LL.B.). He is a
former Associate Fellow at the Society for Advanced Legal Studies and
was a John F. Kennedy Memorial Scholar at Harvard Law School.

About Americord Registry (“Americord”)

Americord Registry is a leader in the advancement of umbilical cord
blood, cord tissue and placenta tissue banking. Americord collects,
processes, and stores newborn stem cells from umbilical cord blood for
future medical or therapeutic use, including the treatment of more than
80 blood diseases such as sickle cell anemia and leukemia. Founded in
2008, Americord is registered with the FDA and operates in all 50
states. The company’s laboratory is CLIA Certified, accredited by the
AABB and complies with all federal and state guidelines and applicable
licenses. Americord is headquartered in New York, NY. For more
information, visit


Alysha Bullock, 866-503-6005